SE548222C2 - A new method to produce an extract composition and its use for the prevention and treatment of disease - Google Patents

A new method to produce an extract composition and its use for the prevention and treatment of disease

Info

Publication number
SE548222C2
SE548222C2 SE2430408A SE2430408A SE548222C2 SE 548222 C2 SE548222 C2 SE 548222C2 SE 2430408 A SE2430408 A SE 2430408A SE 2430408 A SE2430408 A SE 2430408A SE 548222 C2 SE548222 C2 SE 548222C2
Authority
SE
Sweden
Prior art keywords
disease
prevention
produce
treatment
new method
Prior art date
Application number
SE2430408A
Inventor
Atti-La Dahlgren
Original Assignee
Quantum Pharmaceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quantum Pharmaceuticals Sa filed Critical Quantum Pharmaceuticals Sa
Priority to SE2430408A priority Critical patent/SE548222C2/en
Publication of SE548222C2 publication Critical patent/SE548222C2/en

Links

SE2430408A 2024-08-17 2024-08-17 A new method to produce an extract composition and its use for the prevention and treatment of disease SE548222C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE2430408A SE548222C2 (en) 2024-08-17 2024-08-17 A new method to produce an extract composition and its use for the prevention and treatment of disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE2430408A SE548222C2 (en) 2024-08-17 2024-08-17 A new method to produce an extract composition and its use for the prevention and treatment of disease

Publications (1)

Publication Number Publication Date
SE548222C2 true SE548222C2 (en) 2026-04-27

Family

ID=99631868

Family Applications (1)

Application Number Title Priority Date Filing Date
SE2430408A SE548222C2 (en) 2024-08-17 2024-08-17 A new method to produce an extract composition and its use for the prevention and treatment of disease

Country Status (1)

Country Link
SE (1) SE548222C2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089499A1 (en) * 2002-01-15 2005-04-28 Philippe Moussou Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
WO2018222060A1 (en) * 2017-05-29 2018-12-06 Herbiopharm Sp. Z.O.O. Method of preparing a drosera based feed additive
WO2021115610A1 (en) * 2019-12-12 2021-06-17 Quantum Pharmaceuticals Sa Method for preparing a composition and use of the composition for treatment or prophylaxis of disease

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050089499A1 (en) * 2002-01-15 2005-04-28 Philippe Moussou Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
WO2018222060A1 (en) * 2017-05-29 2018-12-06 Herbiopharm Sp. Z.O.O. Method of preparing a drosera based feed additive
WO2021115610A1 (en) * 2019-12-12 2021-06-17 Quantum Pharmaceuticals Sa Method for preparing a composition and use of the composition for treatment or prophylaxis of disease

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Aslam R et al., "Link between gut microbiota dysbiosis and childhood asthma: Insights from a systematic review", J Allergy Clin Immunol Global, available online June 12 2024, Vol. 3, No. 3, pp. 1-11 *
Gänzle, MG, "Food fermentations for improved digestibility of plant foods - an essential ex situ digestion step in agricultural societies?", Current Opinion in Food Science, 2020, Vol. 32, pp. 124-132 *
Hesseltine CW, Chapter 6, Mixed-Culture Fermentations, pp. 52-57 in Applications of Biotechnology in Traditional Fermented Foods, http://www.nap.edu/catalog/1939.html *
Kishimoto N et al., "Purification and properties of an acidic beta-glucosidase from Acidobacterium capsulatum", Journal of Fermentation and Bioengineering, 1991, Vol. 71, No. 5, pp. 318-321 *
Loh JS et al., "Microbiota-gut-brain axis and its therapeutic applications in neurodegenerative diseases", Signal Transduction and Targeted Therapy, (2024)9:37, pp. 1-53, published online 16 February 2024 *
Morsy FH et al., "Novel thermostable glycosidases in the extracellular matrix of the terrestrial cyanobacterium Nostoc commune", J. Gen. Appl. Microbiol., 2008, Vol. 54, pp. 243-252 *
Samtiya M et al., "Enhancing micronutrients bioavailability through fermentation of plant-based foods: A concise Review", Fermentation 2021, 7, 63. https://doi.org/10.3390/fermentation7020063 *

Similar Documents

Publication Publication Date Title
ZA200806703B (en) Methods and compositions for bactéricide, bacteriostatic and anti-inflammation
GB202302434D0 (en) Compositions and method for the treatment of onychomycosis
IL292775A (en) Peripherally acting cannabidiol(cbd)-containing compositions and uses thereof for enhancing female sexual function or treating female sexual disorders
ZA202210984B (en) Methods of treating coronavirus disease 2019
PH12021551975A1 (en) Use of vibegron to treat overactive bladder
PL4243782T3 (en) Tablet for use in treating huntington's disease and method of making the same
BR0311613A (en) Methods for inhibiting, treating or preventing symptoms of skin atrophy, or epithelial or mucosal atrophy in women and use of compound
IL320242A (en) Compounds and their use for treatment of hemoglobinopathies
HUE067796T2 (en) Compositions and methods relating to the treatment of diseases
KR102532946B9 (en) Composition for preventing ameliorating or treating coronavirus infectious disease comprising herbal medicine mixture extract as effective component
GB202502535D0 (en) Treatment and prevention of disease by NRF2 inhibition
GB2607584B (en) Composition and method of treatment
IL319764A (en) Compositions and methods for treatment of huntington's disease
KR102811186B9 (en) Pharmaceutical composition for prevention and treatment of muscle loss comprising Rhododendron mucronulatum extract
DE60236299D1 (en) VALERIANA OFFICINALIS EXTRACT FOR THE TREATMENT OF SLEEP APNEA OR HYPOPNOE
ZA202205968B (en) Herbal composition for treatment of oral related disorders and a method for preparation thereof
ZA202203487B (en) Traditional chinese medicine composition for improving male sexual function by stimulating human potential as well as preparation method and application thereof
WO2010111108A3 (en) Compositions and methods for the treatment of wounds
GB202507901D0 (en) Topical pharmaceutical composition for the treatment and prevention of muscle cramps
GB202011945D0 (en) Compositions and methods relating to the treatment of diseases
GB202003812D0 (en) Compositions and methods relating to the treatment of diseases
GB202003595D0 (en) Compositions and methods relating to the treatment of diseases
GB202314249D0 (en) Compositions and method for treating disease
SE2430407A1 (en) New composition
IL327063A (en) Methods of treating mat2a related diseases